"If a drug has only been tested in younger people, then how do you know it's also going to be good [in someone who is older?], says Raymond Yung, M.D., a professor of geriatric medicine at the University of Michigan and associate director of research at the Department of Veterans Affairs Ann Arbor Geriatric Research Education and Clinical Center
To view a copy of this licence, visit About this article Cite this article Tatge, L., Kim, J., Solano Fonseca, R
Acknowledgements This work was supported by the Medical Research Council [grant numbers MR/J01186X/1, G0901321, MR/M006301/1], (the third grant is a UK New Investigator Research Grant supporting MJB)
Oxidative stress and immune responses during hepatitis C virus infection in Tupaia belangeri
A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism Biol Psychiatry
It breaks the medication down through two key pathways: sulfation and glucuronidation